MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-11-0035469
Sarva Pharmaceuticals Private Limited
Sarva Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4.22 Cr
▼ 39% YoY
Net loss · FY 2024
₹46.67 Lakh
Net margin -11%
EBITDA · FY 2024
-₹34.79 Lakh
EBITDA margin -8.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹2 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
4
As per MCA filings
About Sarva Pharmaceuticals Private Limited
Data last updated:
Sarva Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2014PTC273464. Its GSTIN is 07AAVCS1453R1ZF (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Hem Lata Chaubey and Jai Prakash Chaubey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No: – 993 – 994 Vegas Mall Plot No.6 Sector – 14 Dwarka New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.22 Cr, a decline of 39% compared to the previous year. For the same year it recorded a net loss of ₹46.67 Lakh (net margin -11%) and EBITDA of -₹34.79 Lakh (EBITDA margin -8.2%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 23% over five years.
As per MCA filings, the company has open charges of ₹2 Cr on record.
Sarva Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0035469). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100DL2014PTC273464
Registration Number 273464
Incorporation Date 24 November 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0035469
Recognitions & Rankings of Sarva Pharmaceuticals
Contact details
Sarva Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnit No: – 993 – 994 Vegas Mall Plot No.6 Sector – 14 Dwarka New Delhi, Delhi, India – 110075
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sarva Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sarva Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sarva Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sarva Pharmaceuticals Private Limited, buy the company report.
Financials of Sarva Pharmaceuticals Private Limited
FY 2025 filings availableSarva Pharmaceuticals Private Limited reported revenue of ₹4.22 Cr (down 39% YoY) for FY 2024.
Revenue · FY 2024
₹4.22 Cr ▼ 39%
Net loss · FY 2024
₹46.67 Lakh margin -11%
EBITDA · FY 2024
-₹34.79 Lakh margin -8.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 39%
3 years · compounded
▼ 2%
5 years · compounded
▼ 23%
EBITDA CAGR growth
1 year
▼ 270%
3 years · compounded
▼ 79%
5 years · compounded
▼ 87%
Revenue has declined at a compounded annual rate (CAGR) of 23% over five years, including a 39% fall in the latest year. EBITDA fell 270% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹34.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹46.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.2% | ||||
| Net Profit Margin | -11% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sarva Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sarva Pharmaceuticals Private Limited
Sarva Pharmaceuticals has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hem Lata Chaubey Also directs: Everest Pharmakon Private Limited | Director | 24 Nov 2014 | 11 Years 10 Months | Current |
| Jai Prakash Chaubey Also directs: Everest Pharmakon Private Limited | Director | 24 Nov 2014 | 11 Years 10 Months | Current |
| Prashant Kumar Chaubey | Director | 06 Oct 2021 | 5 Years 0 Months | Current |
| Nishant Chaubey | Director | 06 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Sarva Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| L.L.J.K. Pharmaceuticals Private Limited | ₹4.24 Cr (FY 2024) | 72.0% | Uttar Pradesh, India | |||
| Sarva Pharmaceuticals Private Limitedthis company | ₹4.22 Cr (FY 2024) | -₹46.67 Lakh | -11% | -39.0% | Delhi, India | |
| Sharun Pharmaceuticals Private Limited | ₹4.21 Cr (FY 2024) | -16.0% | Puducherry, India | |||
| Genom Biotech Private Limited | ₹4.2 Cr (FY 2020) | 27.0% | Sinnar, Maharashtra, India |
To see the full peer comparison of Sarva Pharmaceuticals Private Limited, buy the company report.
Auditor
Sarva Pharmaceuticals Private Limited is audited by ASHISH MISHRA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHISH MISHRA & CO. | FY 2023 | 409335 |
Shareholding
The shareholding of Sarva Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sarva Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Feb 2024 | 100883170 | Others | ₹2 Cr | Open |
To see the full charge records of Sarva Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sarva Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sarva Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sarva Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAVCS1453R1ZF | Delhi | Active | 01 Jul 2017 |
| 05AAVCS1453R1ZJ | Uttarakhand | Active | 05 May 2022 |
To see the full GST registrations and return filing status of Sarva Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sarva Pharmaceuticals Private Limited has 4 board changes on record since 2014: 4 appointments. The latest: Nishant Chaubey was appointed as Director on 06 Oct 2021.
AGM
Sarva Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 200.00 Lakh registered on 20 Feb 2024 with Charge ID 100883170 was modified on 03 Apr 2025.
Filing
Sarva Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 100883170 was registered on 20 Feb 2024.
Appointed
Nishant Chaubey was appointed as Director.
Appointed
Prashant Kumar Chaubey was appointed as Director.
Appointed
Hem Lata Chaubey was appointed as Director.
Appointed
Jai Prakash Chaubey was appointed as Director.
Incorporation
24 Nov 2014
Sarva Pharmaceuticals Private Limited was registered on 24 Nov 2014 with Roc Delhi I & aged 11 years 10 months as per MCA records.
Frequently asked questions
Sarva Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 November 2014 (12+ years old) and is registered under CIN U24100DL2014PTC273464.
Sarva Pharmaceuticals has 4 current directors:
- Hem Lata Chaubey - Director
- Jai Prakash Chaubey - Director
- Prashant Kumar Chaubey - Director
- Nishant Chaubey - Director
The latest financial statements of Sarva Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sarva Pharmaceuticals is 07AAVCS1453R1ZF, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAVCS1453R1ZJ (Uttarakhand).
The CIN (Corporate Identification Number) of Sarva Pharmaceuticals is U24100DL2014PTC273464. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sarva Pharmaceuticals was incorporated on 24 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sarva Pharmaceuticals by revenue are L.L.J.K. Pharmaceuticals Private Limited, Sharun Pharmaceuticals Private Limited, Genom Biotech Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nishant Chaubey was appointed as Director on 06 Oct 2021. Prashant Kumar Chaubey was appointed as Director on 06 Oct 2021. Hem Lata Chaubey was appointed as Director on 24 Nov 2014. Sarva Pharmaceuticals has 4 board changes on record in total.
Yes, Sarva Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0035469).
The registered office of Sarva Pharmaceuticals is at Unit No: – 993 – 994 Vegas Mall Plot No.6 Sector – 14 Dwarka New Delhi, Delhi, India – 110075.
Sarva Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.